Suzuki et al. presented the case of a patient with acute COVID-19 with severe lungs involvement, whose elevated syndecan-1 concentration was correlated with their worsening clinical condition and finally decreased as the healing process progressed [44]. This evidence concerns the gene SDC1 and COVID-19.